Skip to main content

Advertisement

SpringerLink
Log in

Bladder augmentation: Complications in the pediatric population

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Bladder augmentation is an invaluable tool for the pediatric urologist, for both the protection of the upper urinary tract and attainment of urinary continence. However, it remains a major surgical undertaking with significant morbidity. This review examines the incidence and pathophysiology of some of the most common and serious complications, which include surgical complications, such as malignancy, bowel obstruction, and bladder perforation, and medical complications including urinary tract infections and gastrointestinal dysfunction. We review the most current and pertinent literature to provide a comprehensive and practical overview of complications from bladder augmentation in the pediatric population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Metcalfe PD, Cain MP, Gilley DA, et al.: What is the Need for Additional Bladder Surgery after Bladder Augmentation in Childhood? Presented at the American Association of Pediatrics Section on Urology Annual Meeting. Washington, DC; October 2005.

  2. Mitchell ME, Piser JA: Intestinocystoplasty and total bladder replacement in children and young adults: followup in 129 cases. J Urol 1987, 138:579–584.

    PubMed  CAS  Google Scholar 

  3. Gearhart JP, Albertsen PC, Marshall FF, Jeffs RD: Pediatric applications of augmentation cystoplasty: the Johns Hopkins experience. J Urol 1986, 136:430–432.

    PubMed  CAS  Google Scholar 

  4. Rink R, Yerkes E, Adams M: Augmentation Cystoplasty. In Pediatric Urology. Edited by Gearhart J, Rink R, Mouriquand P. Philadelphia: WB Saunders; 2001.

    Google Scholar 

  5. Rink R, Hollensbe D, Adams M: Complications of augmentation in children and comparison of gastrointestinal segments. AUA Update Series. 1995, 14:122–128.

    Google Scholar 

  6. Leonard MP, Dharamsi N, Williot PE: Outcome of gastrocystoplasty in tertiary pediatric urology practice. J Urol 2000, 164:947–950.

    Article  PubMed  CAS  Google Scholar 

  7. Lytton B, Green DF: Urodynamic studies in patients undergoing bladder replacement surgery. J Urol 1989, 141:1394–1397.

    PubMed  CAS  Google Scholar 

  8. Hedlund H, Lindstrom K, Mansson W: Dynamics of a continent caecal reservoir for urinary diversion. Br J Urol 1984, 56:366–372.

    PubMed  CAS  Google Scholar 

  9. Berglund B, Kock NG: Volume capacity and pressure characteristics of various types of intestinal reservoirs. World J Surg 1987, 11:798–803.

    Article  PubMed  CAS  Google Scholar 

  10. Radomski SB, Herschorn S, Stone AR: Urodynamic comparison of ileum vs. sigmoid in augmentation cystoplasty for neurogenic bladder dysfunction. Neurourol Urodyn 1995, 14:231–237.

    Article  PubMed  CAS  Google Scholar 

  11. Rosen MA, Light JK: Spontaneous bladder rupture following augmentation enterocystoplasty. J Urol 1991, 146:1232–1234.

    PubMed  CAS  Google Scholar 

  12. Slaton JW, Kropp KA: Conservative management of suspected bladder rupture after augmentation enterocystoplasty. J Urol 1994, 152:713–715.

    PubMed  CAS  Google Scholar 

  13. Metcalfe P, Casale A, Meldrum K, et al.: Spontaneous Perforation of the Augmented Bladder. Presented at the AUA Annual Meeting. San Antonio, TX; May 2005.

  14. DeFoor W, Tackett L, Minevich E, et al.: Risk factors for spontaneous bladder perforation after augmentation cystoplasty. Urology 2003, 62:737–741.

    Article  PubMed  Google Scholar 

  15. Bertschy C, Bawab F, Liard A, et al.: Enterocystoplasty complications in children. A study of 30 cases. Eur J Pediatr Surg 2000, 10:30–34.

    PubMed  CAS  Google Scholar 

  16. Shekarriz B, Upadhyay J, Demirbilek S, et al.: Surgical complications of bladder augmentation: comparison between various enterocystoplasties in 133 patients. Urology 2000, 55:123–128.

    Article  PubMed  CAS  Google Scholar 

  17. Shokeir AA, Shamaa M, el-Mekresh MM, et al.: Late malignancy in bowel segments exposed to urine without fecal stream. Urology 1995, 46:657–661.

    Article  PubMed  CAS  Google Scholar 

  18. Sohn M, Fuzesi L, Deutz F, et al.: Signet ring cell carcinoma in adenomatous polyp at site of ureterosigmoidostomy 16 years after conversion to ileal conduit. J Urol 1990, 143:805–807.

    PubMed  CAS  Google Scholar 

  19. Golomb J, Klutke CG, Lewin KJ, et al.: Bladder neoplasms associated with augmentation cystoplasty: report of 2 cases and literature review. J Urol 1989, 142:377–380.

    PubMed  CAS  Google Scholar 

  20. Husmann DA, Spence HM: Current status of tumor of the bowel following ureterosigmoidostomy: a review. J Urol 1990, 144:607–610.

    PubMed  CAS  Google Scholar 

  21. Filmer RB, Spencer JR: Malignancies in bladder augmentations and intestinal conduits. J Urol 1990, 143:671–678.

    PubMed  CAS  Google Scholar 

  22. Smith P, Hardy GJ: Carcinoma occurring as a late complication of ileocystoplasty. Br J Urol 1971, 43:576–579.

    PubMed  CAS  Google Scholar 

  23. Rink RC, Hensle TW, Kaefer M, Mitchell ME: Complications of Bladder Augmentation-Plenary Lecture. Presented at the AUA Annual Meeting. San Antonio, TX; May 2005.

  24. Kalble T, Tricker AR, Friedl P, et al.: Ureterosigmoidostomy: long-term results, risk of carcinoma and etiological factors for carcinogenesis. J Urol 1990, 144:1110–1114.

    PubMed  CAS  Google Scholar 

  25. Gittes RF: Carcinogenesis in ureterosigmoidostomy. Urol Clin North Am 1986, 13:201–205.

    PubMed  CAS  Google Scholar 

  26. Shands C III, McDougal WS, Wright EP: Prevention of cancer at the urothelial enteric anastomotic site. J Urol 1989, 141:178–181.

    PubMed  Google Scholar 

  27. Chiang MS, Minton JP, Clausen K, et al.: Carcinoma in a colon conduit urinary diversion. J Urol 1982, 127:1185–1187.

    PubMed  CAS  Google Scholar 

  28. Badawi AF: Molecular and genetic events in schistosomiasis-associated human bladder cancer: role of oncogenes and tumor suppressor genes. Cancer Lett 1996, 105:123–138.

    Article  PubMed  CAS  Google Scholar 

  29. Nurse DE, Mundy AR: Assessment of the malignant potential of cystoplasty. Br J Urol 1989, 64:489–492.

    PubMed  CAS  Google Scholar 

  30. Hicks RM, Ismail MM, Walters CL, et al.: Association of bacteriuria and urinary nitrosamine formation with Schistosoma haematobium infection in the Qalyub area of Egypt. Trans R Soc Trop Med Hyg 1982, 76:519–527.

    Article  PubMed  CAS  Google Scholar 

  31. Mirvish SS: Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 1995, 93:17–48.

    Article  PubMed  CAS  Google Scholar 

  32. Crissey MM, Steele GD, Gittes RF: Rat model for carcinogenesis in ureterosigmoidostomy. Science 1980, 207:1079–1080.

    Article  PubMed  CAS  Google Scholar 

  33. Dull BJ, Gittes RF, Goldman P: Nitrate production and phagocyte activation: differences among Sprague-Dawley, Wistar-Furth and Lewis rats. Carcinogenesis 1988, 9:625–627.

    Article  PubMed  CAS  Google Scholar 

  34. Wall BM, Dmochowski RR, Malecha M, et al.: Inducible nitric oxide synthase in the bladder of spinal cord injured patients with a chronic indwelling urinary catheter. J Urol 2001, 165:1457–1461

    Article  PubMed  CAS  Google Scholar 

  35. Austen M, Kalble T: Secondary malignancies in different forms of urinary diversion using isolated gut. J Urol 2004, 172:831–838.

    Article  PubMed  CAS  Google Scholar 

  36. Carr LK, Herschorn S: Early development of adenocarcinoma in a young woman following augmentation cystoplasty for undiversion. J Urol 1997, 157:2255–2256.

    Article  PubMed  CAS  Google Scholar 

  37. Soergel TM, Cain MP, Misseri R, et al.: Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol 2004, 172:1649–1651.

    Article  PubMed  Google Scholar 

  38. Singh G, Thomas DG: Bowel problems after enterocystoplasty. Br J Urol 1997, 79:328–332.

    PubMed  CAS  Google Scholar 

  39. Herschorn S, Hewitt RJ: Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder. Urology 1998, 52:672–678.

    Article  PubMed  CAS  Google Scholar 

  40. Gonzales R, Cabral BPH: Rectal continence enterocystoplasty. Dial Ped Urol 1987, 10:3–4.

    Google Scholar 

  41. King LR: Protection of the Upper Tracts in Undiversion. In Bladder Reconstruction and Continent Urinary Diversion. Chicago: Yearbook Medical Publishers; 1987:127–153.

    Google Scholar 

  42. Barrington JW, Fern-Davies H, Adams RJ, et al.: Bile acid dysfunction after clam enterocystoplasty. Br J Urol 1995, 76:169–171.

    Article  PubMed  CAS  Google Scholar 

  43. Kropp BP, Cheng EY: Bladder Augmentation: Current and Future Techniques. In Clinical Pediatric Urology 4th edn. Edited by Belma BA, King LR, Kram SA. London: Martin Dunitz; 2002:455–490.

    Google Scholar 

  44. Akerlund S: Urinary diversion via the continent ileal reservoir. Functional characteristics and long-term outcome. Scand J Urol Nephrol Suppl 1989, 121:1–36.

    PubMed  CAS  Google Scholar 

  45. Stein R, Lotz J, Andreas J, et al.: Long-term metabolic effects in patients with urinary diversion. World J Urol 1998, 16:292–297.

    Article  PubMed  CAS  Google Scholar 

  46. Salomon L, Lugagne PM, Herve JM, et al.: No evidence of metabolic disorders 10 to 22 years after Camey type I ileal enterocystoplasty. J Urol 1997, 157:2104–2106.

    Article  PubMed  CAS  Google Scholar 

  47. Chadwick Plaire J, Snodgrass WT, Grady RW, Mitchell ME: Long-term followup of the hematuria-dysuria syndrome. J Urol 2000, 164:921–923.

    Article  PubMed  CAS  Google Scholar 

  48. Mingin GC, Stock JA, Hanna MK: Gastrocystoplasty: long-term complications in 22 patients. J Urol 1999, 162:1122–1125.

    Article  PubMed  CAS  Google Scholar 

  49. Nguyen DH, Bain MA, Salmonson KL, et al.: The syndrome of dysuria and hematuria in pediatric urinary reconstruction with stomach. J Urol, 1993, 150:707–709.

    PubMed  CAS  Google Scholar 

  50. Rink R, Renschler T, Adams M, Mitchell M: Long term follow-up of the first gastrocystoplasty series. Presented at the Annual Meeting of the European Society of Pediatric Urology. Tours, France; June 2000.

  51. Dykes EH, Ransley PG: Gastrocystoplasty in children. Br J Urol: 1992, 69:91–95.

    PubMed  CAS  Google Scholar 

  52. Reinberg Y, Manivel JC, Froemming C, Gonzalez R: Perforation of the gastric segment of an augmented bladder secondary to peptic ulcer disease. J Urol 1992, 148:369–371.

    PubMed  CAS  Google Scholar 

  53. Austin PF, DeLeary G, Homsy YL, et al.: Long-term metabolic advantages of a gastrointestinal composite urinary reservoir. J Urol 1997, 158:1704–1707.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Riley Hospital for Children, 702 N Barnhill Drive, Indianapolis, IN, 46202, USA

    Peter D. Metcalfe

Authors
  1. Peter D. Metcalfe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard C. Rink
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter D. Metcalfe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Metcalfe, P.D., Rink, R.C. Bladder augmentation: Complications in the pediatric population. Curr Urol Rep 8, 152–156 (2007). https://doi.org/10.1007/s11934-007-0065-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-007-0065-x

Keywords

Search

Navigation